National Health Act 1953 - Pharmaceutical Benefits - Amendment Determination under subsection 84C(7) No. 2 (15/07/2008)

Overview

The National Health Act 1953, enacted by the Australian Parliament, addresses the need for a comprehensive framework to manage and regulate the healthcare system, including the provision of pharmaceutical benefits. To enhance this framework, the National Health Act 1953 Pharmaceutical Benefits Amendment Determination under subsection 84C (7) No. 2 was introduced on 1 August 2008. This amendment aimed to adjust the additional fee payable for recording the supply of certain pharmaceutical benefits, ensuring that the price does not exceed the patient co-payment. The additional fee, which compensates pharmacists for their services, is indexed annually using the Wage Cost Index. The amendment was made in consultation with the Pharmacy Guild of Australia, reflecting a collaborative approach to updating the safety net provisions for patients requiring a significant number of medicines under the Pharmaceutical Benefits Scheme.

Scope and Application

The National Health Act 1953 Pharmaceutical Benefits Amendment Determination under subsection 84C (7) No. 2 applies to the regulation of pharmaceutical benefits provided under the Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme, specifically focusing on the adjustments to the additional fee charged to patients for the supply of pharmaceutical benefits. This Act applies to the Commonwealth of Australia and extends to individuals and entities involved in the provision of pharmaceutical benefits, including patients, pharmacists, and the Pharmacy Guild of Australia. The Determination is a legislative instrument designed to align the additional fee with the annual adjustment determined by the Wage Cost Index. The amendment involves a minor increase in the additional fee for ready-prepared and extemporaneously-prepared pharmaceutical benefits, ensuring that the fee does not exceed the patient co-payment. This Determination does not introduce any new exclusions or exemptions but rather refines the existing framework to maintain its efficacy and fairness. The implementation of this Determination is subject to consultation and written agreement with the Pharmacy Guild of Australia, as stipulated in the National Health Act 1953.

Key Provisions

The National Health Act 1953 Pharmaceutical Benefits Amendment Determination under subsection 84C (7) No. 2 (the "Determination") modifies the National Health Act 1953 Pharmaceutical Benefits Determination under subsection 84C (7) made on 14 June 2006 (the "Principal Determination"). This amendment primarily adjusts the additional fee for certain pharmaceutical benefits, as outlined in section 4(b)(i) and (ii) of the Schedule. Specifically, the additional fee for ready-prepared pharmaceutical benefits is increased by two cents to $1.03, while the fee for extemporaneously-prepared pharmaceutical benefits is set at $1.42. These changes are intended to reflect the annual adjustment to the additional fee, which compensates pharmacists for recording the supply of pharmaceutical benefits where the Commonwealth price is less than the patient co-payment. Under this Determination, the Act imposes several obligations on parties involved in the supply of pharmaceutical benefits. For instance, the additional fee is indexed annually using the Wage Cost Index, a method that ensures the fee keeps pace with wage increases. This indexing process is critical in maintaining the financial viability of the Safety Net scheme, which provides financial protection for patients who require a large number of pharmaceutical benefits. Furthermore, the Act requires that any adjustment to the additional fee must be agreed upon in writing by the Pharmacy Guild of Australia, as stipulated in section 84C(9) of the Act. This ensures that any changes to the fee structure are made with the consent of the relevant professional body. Failure to comply with the provisions of the Determination could lead to legal repercussions. The Act does not explicitly detail the specific offences, penalties, or consequences for breaches; however, general provisions under the National Health Act 1953 may apply. Such breaches could potentially result in fines or other civil penalties, particularly if they affect the administration of the Pharmaceutical Benefits Scheme or the Safety Net scheme. The exact penalties would depend on the nature and severity of the breach, but they could include administrative penalties or more severe legal actions if the breach results in significant financial or operational disruptions. The Determination is set to commence on 1 August 2008, as stated in section 2 of the Schedule. This commencement date ensures that the changes to the additional fee are implemented in a timely manner, aligning with the annual adjustment cycle. The legal effect of the Determination is to update the Principal Determination, ensuring that the fees charged to pharmacists for recording pharmaceutical benefits remain fair and reflective of current economic conditions. By aligning the additional fee with the Wage Cost Index, the Determination aims to support the ongoing operation of the Safety Net scheme, thereby continuing to provide necessary financial protection to patients.